Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1953
http://purl.obolibrary.org/obo/NCIT_C1953
|
|---|---|
| Preferred Name | Recombinant Interferon Alfa-2b |
| Definitions |
A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. |
|---|---|
| prefLabel | Recombinant Interferon Alfa-2b
|
| label | Recombinant Interferon Alfa-2b
|
| PDQ_Closed_Trial_Search_ID | 462279
|
| code | C1953
|
| Has_Target | |
| prefixIRI | NCIT:C1953
|
| in_subset |
See more
See less
|
| Display_Name | Recombinant Interferon Alfa-2b
|
| Preferred_Name | Recombinant Interferon Alfa-2b
|
| FDA_UNII_Code | 43K1W2T1M6
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Recombinant Interferon Alfa-2b
|
| CAS_Registry |
98530-12-2
99210-65-8
|
| NSC Number | 377523
|
| NCI_Drug_Dictionary_ID | 462279
|
| Legacy Concept Name | Recombinant_Interferon_Alfa-2b
|
| type | |
| ALT_DEFINITION | A drug used to treat some infections caused by viruses and several types of cancer. These include hairy cell leukemia, melanoma, and follicular lymphoma. It is a form of interferon alfa (a substance normally made by cells of the immune system) that is made in the laboratory. It is a type of biological response modifier.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 462279
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0021735
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |